Low-dose IL-2 in birch pollen allergy: A phase-2 randomized double-blind placebo-controlled trial.
- DOI
- 10.1016/j.jaci.2024.10.033
- Published
- 2025 Feb
- Container
- The Journal of allergy and clinical immunology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jaci.2024.10.033,
title = {Low-dose IL-2 in birch pollen allergy: A phase-2 randomized double-blind placebo-controlled trial.},
author = {Rosenzwajg M and Gherasim A and Dietsch F and Beck M and Domis N and Lorenzon R and Chantran Y and Bellier B and Vicaut E and Soria A and de Blay F and Klatzmann D},
year = {2025},
journal = {The Journal of allergy and clinical immunology},
doi = {10.1016/j.jaci.2024.10.033},
url = {https://doi.org/10.1016/j.jaci.2024.10.033}
}RIS
TY - JOUR TI - Low-dose IL-2 in birch pollen allergy: A phase-2 randomized double-blind placebo-controlled trial. AU - Rosenzwajg M AU - Gherasim A AU - Dietsch F AU - Beck M AU - Domis N AU - Lorenzon R AU - Chantran Y AU - Bellier B AU - Vicaut E AU - Soria A AU - de Blay F AU - Klatzmann D PY - 2025 JO - The Journal of allergy and clinical immunology DO - 10.1016/j.jaci.2024.10.033 UR - https://doi.org/10.1016/j.jaci.2024.10.033 ER -
APA
M, R., A, G., F, D., M, B., N, D., R, L., Y, C., B, B., E, V., A, S., F, D. B., & D, K. (2025). Low-dose IL-2 in birch pollen allergy: A phase-2 randomized double-blind placebo-controlled trial.. The Journal of allergy and clinical immunology. https://doi.org/10.1016/j.jaci.2024.10.033
Source records
- pubmed · retrieved 2026-09-26T14:09:50.803Z